ATE554083T1 - Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung - Google Patents

Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung

Info

Publication number
ATE554083T1
ATE554083T1 AT04715495T AT04715495T ATE554083T1 AT E554083 T1 ATE554083 T1 AT E554083T1 AT 04715495 T AT04715495 T AT 04715495T AT 04715495 T AT04715495 T AT 04715495T AT E554083 T1 ATE554083 T1 AT E554083T1
Authority
AT
Austria
Prior art keywords
addition salt
acid addition
producing
base compound
basic compound
Prior art date
Application number
AT04715495T
Other languages
English (en)
Inventor
Kimiyuki Shibuya
Tadaaki Ohgiya
Takayuki Matsuda
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE554083T1 publication Critical patent/ATE554083T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT04715495T 2003-02-28 2004-02-27 Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung ATE554083T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003052700 2003-02-28
PCT/JP2004/002375 WO2004076441A1 (ja) 2003-02-28 2004-02-27 多酸性塩基化合物の酸付加塩の製造方法

Publications (1)

Publication Number Publication Date
ATE554083T1 true ATE554083T1 (de) 2012-05-15

Family

ID=32923406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04715495T ATE554083T1 (de) 2003-02-28 2004-02-27 Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung

Country Status (21)

Country Link
US (2) US7750150B2 (de)
EP (1) EP1598346B1 (de)
JP (2) JP4594863B2 (de)
KR (1) KR101106127B1 (de)
CN (2) CN102702171B (de)
AT (1) ATE554083T1 (de)
AU (1) AU2004215523B2 (de)
BR (1) BRPI0407908A (de)
CA (1) CA2516822C (de)
DK (1) DK1598346T3 (de)
EA (1) EA009045B1 (de)
ES (1) ES2384517T3 (de)
IL (1) IL170093A (de)
IS (1) IS7978A (de)
MX (1) MXPA05009129A (de)
MY (1) MY140618A (de)
NO (1) NO331272B1 (de)
NZ (1) NZ541716A (de)
PL (1) PL378292A1 (de)
TW (2) TWI355384B (de)
WO (1) WO2004076441A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound
US7884106B2 (en) 2003-08-29 2011-02-08 Kowa Company, Ltd. Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
JP5220414B2 (ja) * 2005-08-30 2013-06-26 旭化成ファーマ株式会社 スルホンアミド化合物
US8415372B2 (en) * 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
JP5313125B2 (ja) * 2007-02-28 2013-10-09 旭化成ファーマ株式会社 スルホンアミド誘導体
WO2009004792A1 (ja) * 2007-07-02 2009-01-08 Asahi Kasei Pharma Corporation スルホンアミド化合物及びその結晶
EP2220184B1 (de) * 2007-11-30 2019-03-06 Braggone OY Neue siloxanpolymerzusammensetzungen
CN102711763A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用医药组合物
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
KR20130113921A (ko) 2010-05-19 2013-10-16 코와 가부시키가이샤 비알코올성 지방성 간염의 예방 및/또는 치료제
JP2018524308A (ja) * 2015-06-17 2018-08-30 ギリアード サイエンシーズ, インコーポレイテッド テノホビルアラフェナミドの共結晶、塩および結晶形態
JPWO2018092765A1 (ja) * 2016-11-15 2019-10-17 学校法人同志社 経鼻投与用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112152A (en) * 1994-12-26 2000-11-21 Identa Ltd Process and test kit for cocaine detection
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
WO1998054153A1 (en) * 1997-05-26 1998-12-03 Kowa Company, Ltd. Novel cyclic diamine compounds and medicine containing the same
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
EP1571144A4 (de) * 2002-12-12 2007-08-01 Kowa Co Hydroxyalkylierte cyclischediaminverbindung
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound

Also Published As

Publication number Publication date
NO331272B1 (no) 2011-11-14
NZ541716A (en) 2007-11-30
MXPA05009129A (es) 2005-10-20
NO20054100L (no) 2005-09-22
IS7978A (is) 2005-08-12
US20060079688A1 (en) 2006-04-13
EP1598346A4 (de) 2007-08-15
EP1598346B1 (de) 2012-04-18
JPWO2004076441A1 (ja) 2006-06-01
IL170093A (en) 2012-02-29
CA2516822A1 (en) 2004-09-10
TWI374136B (en) 2012-10-11
CN1753886A (zh) 2006-03-29
CN102702171A (zh) 2012-10-03
EP1598346A1 (de) 2005-11-23
TWI355384B (en) 2012-01-01
CA2516822C (en) 2012-09-25
EA200501379A1 (ru) 2006-02-24
AU2004215523B2 (en) 2009-07-16
US20100234599A1 (en) 2010-09-16
KR20050105218A (ko) 2005-11-03
WO2004076441A1 (ja) 2004-09-10
JP5180998B2 (ja) 2013-04-10
CN102702171B (zh) 2014-09-10
PL378292A1 (pl) 2006-03-20
KR101106127B1 (ko) 2012-01-20
ES2384517T3 (es) 2012-07-06
MY140618A (en) 2009-12-31
EA009045B1 (ru) 2007-10-26
JP4594863B2 (ja) 2010-12-08
TW200504052A (en) 2005-02-01
US7750150B2 (en) 2010-07-06
NO20054100D0 (no) 2005-09-02
CN1753886B (zh) 2012-07-18
JP2010235635A (ja) 2010-10-21
DK1598346T3 (da) 2012-05-29
TW201202218A (en) 2012-01-16
US8518936B2 (en) 2013-08-27
AU2004215523A1 (en) 2004-09-10
BRPI0407908A (pt) 2006-02-14

Similar Documents

Publication Publication Date Title
ATE451380T1 (de) Verfahren zur herstellung von bisphosphonsäureverbindungen
ATE554083T1 (de) Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
ATE552230T1 (de) Verfahren zur herstellung von derivaten aus 1-(2- halobiphenyl-4-yl)-cyclopropancarboxylsäure
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE305919T1 (de) Verfahren zur herstellung von salzen der methallylsulfonsäure
ATE310735T1 (de) Verfahren zur herstellung von spirocyclischen tetronsäurederivaten
ATE455087T1 (de) Verfahren zur herstellung von 2,5- dimethylphenylessigsäure
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
DE60207623D1 (de) Verfahren zur Verbesserung der Viskositätsstabilität durch Zusatz einer wässrigen Färbungszusammensetzung
DE60234279D1 (de) Verfahren zur herstellung eines immunosuppresivums
DE602007005077D1 (de) Verfahren zur Herstellung von Pyridinmethylsulphinylverbindungen
DE602006015458D1 (de) Verfahren zur herstellung eines carbonsäureamidderivats
EP1138675A3 (de) Verfahren zur Herstellung von 2-Methyl-4-amino-5-aminomethylpyrimidin
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
DE602005026841D1 (de) Verfahren zur herstellung von 1,2,2,2-tetrafluor-ethyl-difluor-methylether
DE602004020050D1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
ATE469141T1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
ATE501115T1 (de) Verfahren zur herstellung von entacapon
ATE381532T1 (de) Verfahren zur herstellung von gabapentin
DE502005007096D1 (de) Verfahren zur herstellung von alkenen durch eliminierung von wasser aus alkoholen mit alkylphosphonsäureanhydriden
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE424397T1 (de) Verfahren zur herstellung von losartanderivaten durch chlorierung und reduktion der entsprechenden 1h-imidazol-5-carbaldehyde
TW200700370A (en) Producing method of haloalkylether compounds
DE60221090D1 (de) Verfahren zur Herstellung von 2,6-Dichlorphenolverbindungen